Camellia fascicularis has important ornamental, medicinal, and food value. It also has tremendous potential for exploiting bioactivities. However, the bioactivities of secondary metabolites in C. fascicularis have not been reported. The structures of compounds were determined by spectral analysis and nuclear magnetic resonance (NMR) combined with the available literature on secondary metabolites of C. fascicularis leaves. In this study, 15 compounds were identified, including 5 flavonoids (1–5), a galactosylglycerol derivative (6), a terpenoid (7), 4 lignans (8–11), and 4 phenolic acids (12–15). Compounds 6–7 and 9–12 were isolated from the genus Camellia for the first time. The remaining compounds were also isolated from C. fascicularis for the first time. Evaluation of antioxidant and antimicrobial activities revealed that compounds 5 and 8–11 exhibited stronger antioxidant activity than the positive drug ascorbic acid, while compounds 7, 13, and 15 showed similar activity to ascorbic acid. The minimum inhibitory concentration (MIC) of antibacterial activity for compounds 5, 7, 9, 11, and 13 against Pseudomonas aeruginosa was comparable to that of the positive control drug tetracycline at a concentration of 62.50 µg/mL; other secondary metabolites inhibited Escherichia coli and Staphylococcus aureus at concentrations ranging from 125–250 µg/mL.

One novel C₁₀ polyacetylene rhamnoside, 4,6,8-decatriyne-1-O-α-L-rhamnopyranoside, named xylariside A (1), together with two novel C₁₀ polyacetylene quinovopyranosides, 4,6,8-decatriyne-1-O-α-D-quinovopyranoside, xylariside B (2), and 8E-decaene-4,6-diyne-1-O-α-D-quinovopyranoside, xylariside C (3), were obtained from the solid fermentation of Xylaria sp. VDL4, an endophytic fungus isolated from Vaccinium dunalianum wight (Ericaceae). Their chemical structures were elucidated through a combination of spectroscopic techniques. The antifungal activities of these compounds were evaluated in vitro against four phytopathogenic fungi (Fusarium oxysporum, Botrytis cinerea, Phytophthora capsici, and Fusarium solani). Compound 2 demonstrated significant antifungal activities, with minimum inhibitory concentration (MIC) values ranging from 3.91 to 7.81 μg/mL. Compound 2’s effectiveness levels were similar to those of the reference drugs thiabendazole and carbendazim (each MIC = 0.98−15.62 μg/mL). Xylariside B (2) was further evaluated against B. cinerea in vivo. It exhibited remarkable efficacy in both the prevention and treatment of tomato and strawberry gray mold. Molecular docking studies confirmed the antifungal mechanism of compound 2 by revealing its binding interactions with key enzyme targets in B. cinerea, thereby supporting the observed in vitro and in vivo results. Additionally, compound 2 showed effective inhibition of α-glucosidase, with IC₅₀ values of 5.27 ± 0.0125 μg/mL.

Camellia fascicularis has important ornamental, medicinal, and food values, which also have tremendous potential for exploiting bioactivities. We performed the bioactivity-guided (antioxidant and antimicrobial) screening of eight fractions obtained from the ethyl acetate phase of C. fascicularis. The antioxidant activity was measured by DPPH, ABTS, and FRAP, and the antibacterial activity was measured by the minimum inhibitory concentration (MIC) of Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. The results of bioactivity-guided isolation indicated that the major antioxidant compounds in the ethanolic extracts of C. fascicularis may be present in fractions (Fr.) (A–G, obtained after silica gel column chromatography). Fr. (D–I, obtained after silica gel column chromatography) is a fraction of C. fascicularis with antimicrobial activity. The structures of compounds were determined by spectral analysis and nuclear magnetic resonance (NMR) combined with the available literature on secondary metabolites of C. fascicularis leaves. In this study, 17 compounds were identified, including four phenolics (1, 3–4, and 14), a phenylpropane (2), five terpenoids (5–7, 12, and 15), four flavonoids and flavonoid glycosides (8–10 and 16), and two lignins (13 and 17). Compounds 4–7, 13–15, and 17 were isolated from the genus Camellia for first time. The remaining compounds were also isolated from C. fascicularis for first time. The evaluation of antioxidant and antimicrobial activities revealed that compounds 1, 3, 9, 11, and 17 exhibited higher antioxidant activity than the positive control drug (ascorbic acid), and compounds 4, 8, 10, and 13 showed similar activity to ascorbic acid. The other compounds had weaker or no significant antioxidant activities. The MIC of antibacterial activity for compounds 4, 7, and 11–13 against P. aeruginosa was comparable to that of the positive control drug tetracycline at 125 µg/mL, and other secondary metabolites inhibited E. coli and S. aureus at 250–500 µg/mL. This is also the first report of antioxidant and antimicrobial activities of compounds 5–7, 13–15, and 17. The results of the study enriched the variety of secondary metabolites of C. fascicularis and laid the foundation for further research on the pharmacological efficacy and biological activity of this plant.

The wood of Cryptomeria japonica (Japanese cedar or sugi) is widely used in building and adornment. This study aims to identify the composition of the volatile oils (VOs) extracted from C. japonica solid wood boards by gas chromatography–mass spectroscopy, and to investigate their antimicrobial, anti-inflammatory, and potential neuroprotective activities. A total of 58 volatile organic compounds (VOCs) were identified in the VOs from C. japonica solid wood boards with tree ages of 40, 50, and 60 years (VO-40, 50, and 60), with sandaracopimarinol (13.74–17.59%), ferruginol (10.23–11.29%), abieta-7,13-diene (8.20–13.66%), (+)-δ-cadinene (7.15–9.27%), cis-cubenol (4.36–6.36%), and sandaracopimarinal (3.23–6.04%) as major compounds. The VOs exhibited antifungal potential, especially VO-50 against Aspergillus fumigatus (MIC = 0.312 mg/mL), and VO-60 against Gloeophyllum trabeum (MIC = 1.25 mg/mL). However, VOs exhibited weak antibacterial activity (MIC > 10 mg/mL). Additionally, VOs (10 μg/mL) exhibited anti-inflammatory and potential neuroprotective activities, with VO-60 demonstrating the strongest inhibition of NO (25.79% reduction), TNF-α (52.24% reduction), and IL-6 (27.10% reduction) production in lipopolysaccharide-induced RAW264.7 cells, while increasing cell viability by 70.36% and reducing lactate dehydrogenase release by 41.10% in corticosterone-induced PC12 cells. Correlation and docking analyses revealed that sandaracopimarinal, sandaracopimarinol, β-eudesmol, and ferruginol were the potential active compounds. The results demonstrated that the volatile components from C. japonica solid wood boards not only enhance the board’s decay resistance, but also exhibit therapeutic potential for inflammatory disorders and neuropathic diseases.